LUMENA PHARMACEUTICALS
Lumena Pharmaceuticals is developing oral therapeutics for rare liver diseases to improve liver function, relieve disease symptoms and dramatically impact patient health. The company’s clinical-stage product candidates carry a reduced risk of systemic toxicities by selectively targeting a transporter in the intestine and are designed to be minimally absorbed in the body. Lumena’s lead candidate, LUM001, has been extensively evaluated in other indications across 12 clinical studies in more th... an 1,400 subjects. Because of the extensive preclinical and clinical data package for a compound at this stage in development, LUM001 is positioned to rapidly progress through the clinic in pediatric and adult patients with several types of cholestatic liver disease. While Lumena’s primary focus is to develop novel treatments for patients with rare liver diseases, the company’s therapeutic approach also has promising potential in the treatment of metabolic diseases affecting the liver, a significant and growing health problem in children and adults.
LUMENA PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.lumenapharma.com
Total Employee:
5001+
Status:
Active
Contact:
+353 1 429 7700
Email Addresses:
[email protected]
Total Funding:
70.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail GoDaddy DNS Ubuntu
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aragon Pharmaceuticals
Aragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer.
BioMimetix Pharmaceutical
BioMimetix Pharmaceutical develops therapeutic compounds for various diseases and treatment ramifications such as radiation toxicity.
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
Mapp Biopharmaceutical
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Current Advisors List
Founder
Investors List
Pappas Ventures
Pappas Ventures investment in Series B - Lumena Pharmaceuticals
Alta Partners
Alta Partners investment in Series B - Lumena Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series B - Lumena Pharmaceuticals
RiverVest
RiverVest investment in Series B - Lumena Pharmaceuticals
Adage Capital Management
Adage Capital Management investment in Series B - Lumena Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series B - Lumena Pharmaceuticals
Sanofi Ventures
Sanofi Ventures investment in Series A - Lumena Pharmaceuticals
Alta Partners
Alta Partners investment in Series A - Lumena Pharmaceuticals
RiverVest
RiverVest investment in Series A - Lumena Pharmaceuticals
Pappas Ventures
Pappas Ventures investment in Series A - Lumena Pharmaceuticals
Official Site Inspections
http://www.lumenapharma.com
- Host name: 157.245.237.44
- IP address: 157.245.237.44
- Location: Santa Clara United States
- Latitude: 37.3417
- Longitude: -121.9753
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95051
